2C-B-morpholine

2C-B-morpholine, also known as 2C-B-norphenmetrazine or as 2-(4-bromo-2,5-dimethoxyphenyl)morpholine, is a serotonin receptor modulator of the phenylmorpholine (phenmetrazine) and cyclized phenethylamine groups. It is a ligand of the serotonin 5-HT2A receptor, with an affinity of 20.6 nM and an EmaxTooltip maximal efficacy of 4%. The drug showed 103-fold lower affinity for this receptor than R(–)-DOB and had minimal agonist activity (with R(–)-DOB having an Emax of 51% in the assay), so for practical purposes would act as an antagonist at the 5-HT2A receptor under most circumstances, despite being technically classified as a partial agonist.
2C-B-morpholine was first described in the scientific literature by Richard Glennon and colleagues by 2004.
== See also == Substituted phenethylamine § Cyclized phenethylamines Substituted phenylmorpholine LPH-5 2C-B-aminorex 2C-B-3PIP 2C-B-PP 2C-B-BZP
== References ==
== External links == 2C-B-morpholine - Isomer Design
Wikipedia contributors, "2C-B-morpholine", Wikipedia, revision 1338239275, retrieved 20 November 2026, source, CC BY-SA 4.0.